Literature DB >> 14630890

The value of cardiac enzymes in elderly patients presenting to the emergency department with syncope.

Shamai A Grossman1, Sara Van Epp, Ryan Arnold, Richard Moore, Lily Lee, Nathan I Shapiro, Richard E Wolfe, Lewis A Lipsitz.   

Abstract

BACKGROUND: Most patients admitted to the hospital from the emergency department (ED) with syncope do not have a myocardial infarction (MI), yet a common practice is to draw serial cardiac enzymes.
METHODS: To assess the value of serial cardiac enzymes in elderly patients who present to the ED with syncope, a retrospective chart review was performed on consecutive patients aged 65 and older with syncope in an urban teaching hospital ED between July 1, 1998 and June 30, 1999. Charts were screened for presenting history, cardiac risk factors, testing, and outcomes including acute coronary syndromes, MI, death, and patients returning to the ED or admitted within 72 hours of discharge.
RESULTS: 319 patients met the study criteria of syncope with confirmed loss of consciousness in the absence of seizure or stroke. 141 of 228 admitted patients (62%) had creatine phosphokinase (CPK) drawn and 5% of these had Troponin I (TnI). 3 of 141 patients, or 2.1% (95% CI [confidence interval]: 0.04%-6.09%), had positive cardiac enzymes during their hospitalization. CPK was positive in all 3, and TnI, drawn in 1 patient, was also positive. Two of these patients had chest discomfort and ST segment and T-wave abnormalities on electrocardiogram (ECG) in addition to a syncopal event. The third patient had dementia and could not recall the details surrounding her syncopal event. In addition, her baseline ECG demonstrated a left bundle branch block, limiting ECG interpretation.
CONCLUSIONS: Cardiac enzymes may be of little additional value if drawn routinely on elderly patients with syncope who are admitted to the hospital from the ED, unless they have other signs or symptoms suggestive of myocardial ischemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630890     DOI: 10.1093/gerona/58.11.m1055

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  8 in total

1.  Testing in syncope.

Authors:  Shamai A Grossman
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

Review 2.  Collapse query cause: the management of adult syncope in the emergency department.

Authors:  M J Reed; A Gray
Journal:  Emerg Med J       Date:  2006-08       Impact factor: 2.740

3.  Substance abuse in emergency department patients with unexplained syncope.

Authors:  Zev Wiener; David Te-Wei Chiu; Nathan Ivan Shapiro; Shamai Aron Grossman
Journal:  Intern Emerg Med       Date:  2013-12-03       Impact factor: 3.397

4.  Predictors of 30-day serious events in older patients with syncope.

Authors:  Benjamin C Sun; Stephen F Derose; Li-Jung Liang; Gelareh Z Gabayan; Jerome R Hoffman; Alison A Moore; William R Mower; Carol M Mangione
Journal:  Ann Emerg Med       Date:  2009-09-19       Impact factor: 5.721

5.  Yield of diagnostic tests in evaluating syncopal episodes in older patients.

Authors:  Mallika L Mendu; Gail McAvay; Rachel Lampert; Jonathan Stoehr; Mary E Tinetti
Journal:  Arch Intern Med       Date:  2009-07-27

6.  Utility of Chest Radiography in Emergency Department Patients Presenting with Syncope.

Authors:  Matthew L Wong; David Chiu; Nathan I Shapiro; Shamai A Grossman
Journal:  West J Emerg Med       Date:  2016-11-02

7.  Using the Boston Syncope Observation Management Pathway to Reduce Hospital Admission and Adverse Outcomes.

Authors:  Oren J Mechanic; Celine Y Pascheles; Gregory J Lopez; Alina M Winans; Nathan I Shapiro; Carrie Tibbles; Richard E Wolfe; Shamai A Grossman
Journal:  West J Emerg Med       Date:  2019-02-04

8.  Etiology, risk factors, and prognosis of patients with syncope: A single-center analysis.

Authors:  Lin Ling; Tingting Feng; Xiaofeng Xue; Zicheng Ling
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-09-28       Impact factor: 1.468

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.